Inspire Medical Systems, Inc.
NYSE:INSP
192.71 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -21.153 | -44.881 | -42.042 | -57.203 | -33.243 | -21.828 | -17.511 | -18.528 | -21.337 |
| Depreciation & Amortization
| 2.846 | 1.858 | 1.218 | 0.84 | 0.495 | 0.393 | 0.285 | 0.103 | 0.12 |
| Deferred Income Tax
| -2.469 | 0 | 0.014 | -0.022 | -0.983 | -0.053 | 0.1 | -0.195 | 0.012 |
| Stock Based Compensation
| 82.823 | 51.97 | 26.178 | 12.817 | 6.197 | 1.219 | 0.243 | 0.248 | 0.305 |
| Change In Working Capital
| -40.781 | 1.81 | -6.855 | -10.878 | -6.574 | 0.861 | 0.777 | 0.243 | -1.404 |
| Accounts Receivables
| -30.218 | -27.017 | -9.244 | -11.842 | -6.48 | -2.836 | -1.767 | -0.76 | -0.261 |
| Inventory
| -21.999 | 5.345 | -8.752 | -2.645 | -3.167 | 1.003 | -0.315 | 0.612 | -1.514 |
| Accounts Payables
| 9.296 | 14.355 | 4.779 | 2.048 | 1.034 | 0.439 | 1.825 | -0.48 | 0.418 |
| Other Working Capital
| 42.921 | 9.127 | 6.362 | 1.561 | 2.039 | 2.255 | 1.034 | 0.871 | -0.047 |
| Other Non Cash Items
| 3.74 | 0.812 | 1.368 | 1.401 | 1.262 | 0.714 | 0.315 | 0.18 | 0.05 |
| Operating Cash Flow
| 24.653 | 11.569 | -20.119 | -53.045 | -32.846 | -18.694 | -15.791 | -17.949 | -22.254 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -23.629 | -9.096 | -4.668 | -2.455 | -2.739 | -0.25 | -0.412 | -0.306 | -0.346 |
| Acquisitions Net
| 271.193 | 0 | -33.807 | -89.082 | 40.82 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -281.439 | -10.5 | -9.993 | -52.721 | -178.074 | -115.481 | -8.969 | 0 | 0 |
| Sales Maturities Of Investments
| 10.246 | 0 | 43.8 | 141.803 | 137.254 | 32.342 | 1.781 | 0 | 23.91 |
| Other Investing Activites
| -271.193 | -10.5 | 33.807 | 89.082 | -40.82 | -83.139 | -7.188 | 0 | 23.91 |
| Investing Cash Flow
| -294.822 | -19.596 | 29.139 | 86.627 | -43.559 | -83.389 | -7.6 | -0.306 | 23.564 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | -24.5 | 0 | 0 | 0 | -8 | -0.458 | 0 | -7 |
| Common Stock Issued
| 31.108 | 259.62 | 14.948 | 134.065 | 2.495 | 181.825 | 25.203 | 12.814 | 0.042 |
| Common Stock Repurchased
| -17.158 | -0.043 | 3.472 | 2.361 | 1.355 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 31.108 | -0.043 | -3.472 | 134.065 | 1.964 | 8.558 | 25.661 | 12.814 | 9.542 |
| Financing Cash Flow
| 13.95 | 235.077 | 14.948 | 134.065 | 1.964 | 190.383 | 25.661 | 12.814 | 2.542 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0.164 | 0.075 | -0.019 | 0.011 | 0.013 | 0.033 | 0 | 0 | 0 |
| Net Change In Cash
| -256.055 | 227.125 | 23.949 | 167.658 | -74.428 | 88.333 | 2.27 | -5.441 | 3.852 |
| Cash At End Of Period
| 185.537 | 441.592 | 214.467 | 190.518 | 22.86 | 97.288 | 8.955 | 6.685 | 12.126 |